Sanofi filed a complaint that alleged Seikagaku-developed and Zimmer-distributed Gel-One product infringed its patent for treating knee arthritis. A federal jury ruled last month that the patent includes administration through a single injection rather than multiple injections. The patent was also ruled invalid because it included "obvious variations of earlier work."
Zimmer Wins Patent Infringement Case FeaturedWritten by Jaimie Oh | August 07, 2012
Zimmer Holdings and Tokyo-based Seikagaku have won a patent infringement lawsuit filed by Sanofi, according to a Bloomberg Businessweek report.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.